M&A, patents & pricing, tech invasion may define Indian pharma in 2014
This article was originally published in Scrip
Executive Summary
Brace for more action in India, with "opportunistic" mergers and acquisitions (M&A), patent and pricing related issues and a tech thrust among the key trends likely to shape the pharmaceutical sector in 2014, according some industry pundits.